Jubilant Group's promoter Bhartia family is likely to offload small stakes in the group's listed firms through block deals, CNBC-Awaaz reported on June 12 citing sources.
The channel reported that the promoter will sell 1.32 crore shares of Jubilant Food, 56 lakh shares of Jubilant Pharmova and 1.2 crore shares of Jubilant Ingrevia.
In Jubilant Food, the promoter will sell 2% stake at floor price of Rs 641 per share and Morgan stanley will be the broker to the deal, the channel reported.
The promoter will sell 7.53% stake in Jubilant Ingrevia at floor price of Rs 627.45 per share, which represents 8% discount from current market price, reported CNBC-Awaaz.
In Jubilant Pharmova, 3.5% stake is likely to be sold at floor price of Rs 1,013 per share, which represents 9.9% discount to current market price.
Earlier on June 12, Moneycontrol reported, citing sources, that the Bhartia family is eyeing block deals to part-fund a 40% stake in Hindustan Coca Cola Beverages (HCCB), the Indian bottling business of the American soft drinks giant.
It was in December that the Jubilant Bhartia Group announced that it had entered into a definitive agreement to acquire a 40 percent equity interest in Hindustan Coca Cola Holdings (HCCH) through Jubilant Beverages Ltd for a purchase consideration of Rs 12,500 crore.
HCCH is the parent company of HCCB, the largest Coca‐Cola bottler in India.
Jubilant FoodWorks is the master franchisee of Domino’s Pizza in India, Nepal, Sri Lanka and Bangladesh. It also operates Dunkin’ Donuts and Popeyes in India, alongside homegrown brands Ekdum! and Hong’s Kitchen. As of June 12, its market capitalisation was around Rs 43,795 crore.
Jubilant Pharmova, the group’s pharmaceuticals and contract research arm, has a presence in the sterile injectables, CRO services and novel drug development businesses, allergenic extracts and US radio-pharmacy networks. It has a market cap of Rs 17,760 crore.
Jubilant Ingrevia is the group’s demerged life‑sciences and specialty chemicals company, producing ingredients such as vitamins B3 and B4, pyridine derivatives and ethanol along with CDMO services. Its market cap stood at Rs 10,753 crore as of June 12.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
